|EXCHANGE:||CBOE BZX Exchange, Inc.|
|INCEPTION DATE:||December 8, 2020|
|NET ASSETS AS OF|
|30-DAY SEC YIELD AS OF 02/28/2021||0.06%|
|Median 30 Day Bid/Ask Spread|
Fund Investment Objective
The TrimTabs Donoghue Forlines Risk Managed Innovation ETF seeks to track investment results of TrimTabs Donoghue Forlines Risk Managed Free Cash Flow Innovation Index that provides risk-managed exposure to U.S. publicly traded companies with strong free cash flow and strong research and development (“R&D”) investment.
Where does DFNV fit into a portfolio?
The TrimTabs Donoghue Forlines Risk Managed Innovation ETF is a strategic allocation to investor portfolios that fits outside of traditional “style box” portfolio construction. Because technology is embedded in every sector of the new economy, innovation cannot be boxed into sectors or styles. This ETF is a core position as part of an overall asset allocation to equities.
Why invest in DFNV?
DFNV provides risk-managed exposure to publicly traded companies with strong free cash flow and strong research and development (R&D) investment
Advances in technology and healthcare are now embedded in every sector of the global economy (financial services, manufacturing, consumer discretionary first among them), which potentially changes how returns in the equity markets, public and private, may be produced in the future; DFNV is constructed to identify and adapt to those trends.
R&D spending combined with strong free cash flow generation have been responsible for a subset of corporations’ emergence as new leaders in global markets; DFNV includes companies across all sectors that maintain high R&D intensity and strong free cash flow generation
We believe that the combination of our R&D /Free Cash Flow Innovation with Risk Management is a breakthrough in Index and ETF construction.